UPAR

(redirected from Urokinase-Type Plasminogen Activator Receptor)
AcronymDefinition
UPARUrokinase-Type Plasminogen Activator Receptor (also seen as u-PAR)
UPARUnit Public Affairs Representative
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Soluble urokinase-type plasminogen activator receptor levels in patients with schizophrenia.
Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study.
Bhattachar for their insightful comment [1] on our article suggesting a role of low-grade cellular-based inflammation as indicated by elevated soluble urokinase-type plasminogen activator receptor (suPAR) plasma concentrationon in the pathogenesis of high altitude pulmonary edema (HAPE) [2].
Taccone et al., "Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients," Journal of Critical Care, vol.
uPA binds tightly ([K.sub.D] < 1nm) [76] to cell-surface receptor urokinase-type plasminogen activator receptor (uPAR) through its GFD [77, 78], although it also binds and activates plasminogen on platelets, which do not express uPAR [79].
Soluble urokinase-type plasminogen activator receptor (suPAR) has recently been suggested as a potential circulating factor in FSGS [9-13].
(6) Further, endotoxin-mediated urokinase-type plasminogen activator receptor expression, important in neutrophil recruitment, has been found to be mediated through tyrosine phosphorylation of phosphoglycerate kinase.
Urokinase-type plasminogen activator receptor is associated with macrophages and plaque rupture in symptomatic carotid atherosclerosis.
The receptor can also bind molecules that are not marked by M6P such as IGF-II, retinoic acid, urokinase-type plasminogen activator receptor, and plasminogen.
5,942,492, "Cyclic Peptides That Bind To Urokinase-Type Plasminogen Activator Receptor" covers a broad class of cyclic peptides that Angstrom is developing to inactivate or alternatively to target a key receptor involved in the tumor angiogenesis and tumor metastasis.
Serrati, "Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, [beta]2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: Failure of association in systemic sclerosis endothelial cells," Arthritis and Rheumatism, vol.